Find clinical trials for Kidney Disease in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Kidney Disease trials near Nashville, TN, USA:
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...
Phase 2
Nashville, Tennessee, United States and 91 other locations
The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...
Phase 2
Nashville, Tennessee, United States and 88 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Nashville, Tennessee, United States and 330 other locations
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...
Phase 3
Nashville, Tennessee, United States and 103 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
Nashville, Tennessee, United States and 97 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Nashville, Tennessee, United States and 755 other locations
disease (ASCVD) or diabetes with end stage kidney disease (ESKD) undergoing maintenance dialysis....
Phase 2, Phase 3
Nashville, Tennessee, United States and 546 other locations
The purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharm...
Phase 2
Nashville, Tennessee, United States of America and 41 other locations
The purpose of this study is to determine if zigakibart is safe and effective for long-term use in patients with immunoglobulin A nephropathy (IgAN)....
Phase 3
Brentwood, Tennessee, United States and 19 other locations
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
Phase 1, Phase 2
Nashville, Tennessee, United States and 8 other locations
Clinical trials
Research sites
Resources
Legal